한글목차

약물 재창출 시장(2024-2028년)

약물 재창출 시장은 2023년부터 2028년까지 85억 7,840만 달러 규모로 확대될 것으로 예측되며, 예측 기간 동안 4.3%의 CAGR로 성장할 것으로 예상됩니다. 이 보고서는 약물 재창출 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

이 보고서는 현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 암 치료에 대한 약물 재창출의 사용 확대, 약물 재창출의 비용 효율성, 약물 재창출이 희귀질환 치료의 유력한 대안으로 부상하고 있는 점 등이 이 시장을 주도하고 있습니다.

이 보고서는 약물 재창출에 대한 투자가 향후 몇 년 동안 약물 재창출 시장의 성장을 촉진하는 주요 이유 중 하나로 꼽고 있습니다. 또한, 벤더 간 제휴 및 공동 연구, AI를 활용한 기존 약물의 재사용도 시장의 큰 수요를 창출할 것으로 예상됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio에 의한 분석

• 가격 민감도·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 혼란 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 상황

• 시장 생태계
• 시장의 특징
• 밸류체인 분석

제4장 시장 규모 평가

• 시장 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제5장 시장 규모 실적

• 약물 재창출 세계 시장(2018-2022년)
• 종류별 분석(2018-2022년)
• 제품 종류별 분석(2018-2022년)
• 지역별 분석(2018-2022년)
• 국가별 분석(2018-2022년)

제6장 정성 분석

• 세계의 약물 재창출 시장에 대한 AI의 영향

제7장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제8장 시장 세분화 : 종류별

• 시장 세분화
• 비교 : 종류별
• 의약품 중심적 : 시장 규모와 예측(2023-2028년)
• 질환 중심적 : 시장 규모와 예측(2023-2028년)
• 타겟 중심적 : 시장 규모와 예측(2023-2028년)
• 종류별 시장 기회

제9장 시장 세분화 : 제품 종류별

• 시장 세분화
• 비교 : 제품 종류별
• 소분자 : 시장 규모와 예측(2023-2028년)
• 생물학적 제제 : 시장 규모와 예측(2023-2028년)
• 제품 종류별 시장 기회

제10장 고객 상황

• 고객 상황 개요

제11장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 인도 : 시장 규모와 예측(2023-2028년)
• 프랑스 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 캐나다 : 시장 규모와 예측(2023-2028년)
• 호주 : 시장 규모와 예측(2023-2028년)
• 브라질 : 시장 규모와 예측(2023-2028년)
• 지역별 시장 기회

제12장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제13장 경쟁 상황

• 개요
• 경쟁 상황
• 혼란 상황
• 업계 리스크

제14장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca Plc
• Biogen Inc.
• Bristol Myers Squibb Co.
• Eli Lilly and Co.
• Gilead Sciences Inc.
• Johnson and Johnson Services Inc.
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd.
• Vertex Pharmaceuticals Inc.

제15장 부록

영문목차

Drug Repurposing Market 2024-2028

The drug repurposing market is forecasted to grow by USD 8578.4 million during 2023-2028, accelerating at a CAGR of 4.3% during the forecast period. The report on the drug repurposing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing use of drug repurposing for cancer treatment, cost effectiveness of drug repurposing, and drug repurposing emerging as viable option for rare disease treatment.

Technavio's drug repurposing market is segmented as below:

By Type

• Drug-centric
• Disease-centric
• Target-centric

By Product Type

• Small molecules
• Biologics

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the investment in drug repurposing as one of the prime reasons driving the drug repurposing market growth during the next few years. Also, partnerships and collaborations among vendors and using ai to repurpose existing drugs will lead to sizable demand in the market.

The report on the drug repurposing market covers the following areas:

• Drug Repurposing Market sizing
• Drug Repurposing Market forecast
• Drug Repurposing Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug repurposing market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biogen Inc., Bristol Myers Squibb Co., Eli Lilly and Co., Gilead Sciences Inc., Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., and Vertex Pharmaceuticals Inc.. Also, the drug repurposing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value Chain Analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2023
• 4.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

• 5.1 Global Drug Repurposing Market 2018 - 2022
  • Historic Market Size - Data Table on Global Drug Repurposing Market 2018 - 2022 ($ million)
• 5.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 5.3 Product Type segment analysis 2018 - 2022
  • Historic Market Size - Product Type Segment 2018 - 2022 ($ million)
• 5.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 5.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Drug Repurposing Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 7.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Type

• 8.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 8.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 8.3 Drug-centric - Market size and forecast 2023-2028
  • Chart on Drug-centric - Market size and forecast 2023-2028 ($ million)
  • Data Table on Drug-centric - Market size and forecast 2023-2028 ($ million)
  • Chart on Drug-centric - Year-over-year growth 2023-2028 (%)
  • Data Table on Drug-centric - Year-over-year growth 2023-2028 (%)
• 8.4 Disease-centric - Market size and forecast 2023-2028
  • Chart on Disease-centric - Market size and forecast 2023-2028 ($ million)
  • Data Table on Disease-centric - Market size and forecast 2023-2028 ($ million)
  • Chart on Disease-centric - Year-over-year growth 2023-2028 (%)
  • Data Table on Disease-centric - Year-over-year growth 2023-2028 (%)
• 8.5 Target-centric - Market size and forecast 2023-2028
  • Chart on Target-centric - Market size and forecast 2023-2028 ($ million)
  • Data Table on Target-centric - Market size and forecast 2023-2028 ($ million)
  • Chart on Target-centric - Year-over-year growth 2023-2028 (%)
  • Data Table on Target-centric - Year-over-year growth 2023-2028 (%)
• 8.6 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Product Type

• 9.1 Market segments
  • Chart on Product Type - Market share 2023-2028 (%)
  • Data Table on Product Type - Market share 2023-2028 (%)
• 9.2 Comparison by Product Type
  • Chart on Comparison by Product Type
  • Data Table on Comparison by Product Type
• 9.3 Small molecules - Market size and forecast 2023-2028
  • Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
  • Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
  • Chart on Small molecules - Year-over-year growth 2023-2028 (%)
  • Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
• 9.4 Biologics - Market size and forecast 2023-2028
  • Chart on Biologics - Market size and forecast 2023-2028 ($ million)
  • Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
  • Chart on Biologics - Year-over-year growth 2023-2028 (%)
  • Data Table on Biologics - Year-over-year growth 2023-2028 (%)
• 9.5 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)
  • Data Table on Market opportunity by Product Type ($ million)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 11.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 11.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 11.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 11.8 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 11.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 11.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 11.11 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ million)
  • Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
• 11.12 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
• 11.13 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 11.14 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 11.15 Australia - Market size and forecast 2023-2028
  • Chart on Australia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Australia - Market size and forecast 2023-2028 ($ million)
  • Chart on Australia - Year-over-year growth 2023-2028 (%)
  • Data Table on Australia - Year-over-year growth 2023-2028 (%)
• 11.16 Brazil - Market size and forecast 2023-2028
  • Chart on Brazil - Market size and forecast 2023-2028 ($ million)
  • Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
  • Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
• 14.5 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
  • SWOT
• 14.6 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
  • SWOT
• 14.7 Biogen Inc.
  • Biogen Inc. - Overview
  • Biogen Inc. - Product / Service
  • Biogen Inc. - Key news
  • Biogen Inc. - Key offerings
  • SWOT
• 14.8 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
  • SWOT
• 14.9 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key offerings
  • SWOT
• 14.10 Gilead Sciences Inc.
  • Gilead Sciences Inc. - Overview
  • Gilead Sciences Inc. - Product / Service
  • Gilead Sciences Inc. - Key news
  • Gilead Sciences Inc. - Key offerings
  • SWOT
• 14.11 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
  • SWOT
• 14.12 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
  • SWOT
• 14.13 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 14.14 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 14.15 Regeneron Pharmaceuticals Inc.
  • Regeneron Pharmaceuticals Inc. - Overview
  • Regeneron Pharmaceuticals Inc. - Product / Service
  • Regeneron Pharmaceuticals Inc. - Key offerings
  • SWOT
• 14.16 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • SWOT
• 14.17 Vertex Pharmaceuticals Inc.
  • Vertex Pharmaceuticals Inc. - Overview
  • Vertex Pharmaceuticals Inc. - Product / Service
  • Vertex Pharmaceuticals Inc. - Key offerings
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations
  • o Strong geographic presence